Skip to main content
Premium Trial:

Request an Annual Quote

University of Texas Southwestern Receives $1.78 Million from NIH for Obesity Research

NEW YORK, Oct. 1 (GenomeWeb News) - The University of Texas Southwestern has received a three-year, $1.78 million grant for obesity research as part of the National Institutes of Health's Roadmap for Medical Research.


According to the university, a team of 24 investigators led by Gregory Fitz, the head of the Taskforce for Obesity Research at Southwestern, will examine the behavioral, metabolic and molecular mechanisms that cause obesity and metabolic syndrome. The research will focus on the brain and liver because these organs play key roles in the development of obesity and related disorders.


Jay Horton, the UT Southwestern researcher who was the principal investigator of the NIH grant, said he hopes the funding will provide a formal mechanism for investigators to come together under one umbrella to focus on solving one disease.


"Hopefully, our efforts will provide bigger steps toward understanding the metabolic processes that lead to obesity," he said.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.